ArticleAIDS research and therapy2024

Brief communications: changes in inflammatory biomarkers and lipid profiles after switching to long-acting cabotegravir plus rilpivirine.

Eisuke Adachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.